SL BIO Ltd. and Horizon Space Acquisition II Corp. Announce Registration Statement Effectiveness and Extraordinary General Meeting Date to Approve Business Combination
(NASDAQ:SLBT),(NasdaqGM:HSPT), TAIPEI, Taiwan & NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) — SL BIO Ltd. (“SL Bio” or the “Company”), a biomedical company specializing in developing innovative cellular and gene therapies, and Horizon Space Acquisition II Corp. (Nasdaq: HSPT) (“HSPT”), a publicly traded special purpose acquisition company , today announced that the registration statement on […]